Search

everythinglearnresearchcommunity

for

Search:↓

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Thorough evaluation is crucial for postmenopausal women with virilization to detect rare ovarian tumors.

Doctors should know how to diagnose and treat PCOS, which often involves checking for high male hormone levels and using medications to manage symptoms.

The case showed the need for quick investigation of virilization in women and how emotional health is linked to physical health.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

The document concludes that PCOS in adolescents is complex and requires comprehensive care to manage its symptoms and associated health risks.

Most women with excess hair growth need only a clinical evaluation and minimal tests unless they show signs of virilism.

The statement offers guidance for hormone therapy and surgery to help gender-incongruent adults affirm a male identity.

Many transgender men on testosterone therapy experience hair loss.

Many young women who donate blood have hormonal disorders like excess male hormones and PCOS.

CAH is a genetic disorder affecting cortisol production and causing hormonal imbalances, with treatment and diagnosis varying by form and symptoms.

A rare ovarian tumor caused early puberty signs in a 1-year-old girl, but surgery reduced hormone levels.

PCOS starts in adolescence with hormonal issues, leading to adult health problems, and early treatment is crucial.

Hormone therapy in transgender individuals can increase acne and affect hair growth and loss.

Masculinizing hormone therapy increases the risk of hair loss in transgender and gender-diverse patients.

A woman with a rare hormone resistance condition also had missing teeth and hair loss, which might be new symptoms of her genetic disorder.

High androgen levels in postmenopausal women may suggest an ovarian tumor, and removing it can improve heart and metabolic health.

Thyroid hormone therapy effectively treated the man's rare muscle and heart issues.

Androstanediol glucuronide is a reliable marker for hirsutism in women.

The severity of symptoms in nonclassical congenital adrenal hyperplasia is not determined by CYP21A2 gene variations.

Identifying nonclassic congenital adrenal hyperplasia and carriers of CYP21 mutations is challenging, and genetic counseling is recommended due to their prevalence.

Some conditions mimic PCOS symptoms and need careful diagnosis to treat potentially serious health issues.

About 13% of women had idiopathic hirsutism and 8.5% had polycystic ovary syndrome in a group of Iranian women.

The update highlights that non-classic congenital adrenal hyperplasia is common in women with excess male hormones, requires specific hormone tests for diagnosis, and has various treatment options depending on age and symptoms.

High androgen levels in Chinese women with PCOS are linked to a higher risk of diabetes and obesity.

Men with early balding may have hormonal imbalances similar to women with PCOS and could benefit from similar treatments.

Female pattern hair loss is common in women with polycystic ovarian syndrome.

The guideline emphasizes a multidisciplinary approach and informed consent for gender-affirming hormone treatment, with regular follow-ups and individualized care.